trending Market Intelligence /marketintelligence/en/news-insights/trending/akg3tswxxw5ctvbjblzwyq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Coherus BioSciences appoints former Anthem exec to board

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Coherus BioSciences appoints former Anthem exec to board

Coherus Biosciences Inc. appointed Samuel Nussbaum to its board of directors.

The appointee is the former vice president of clinical health policy and chief medical officer of Anthem Inc., having served in those roles from 2000 to 2016.

The Redwood City, Calif.-based company said Nussbaum's appointment will help with Coherus' efforts to introduce its biosimilar medicines in the market.